MA20499A1 - Derives d'indole - Google Patents

Derives d'indole

Info

Publication number: MA20499A1
Authority: MA; Morocco
Prior art keywords: indole derivatives; indole; derivatives
Prior art date: 1984-08-01

Application number

MA20725A

Other languages

English (en)

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-08-01

Filing date

1985-08-01

Publication date

1986-04-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10564759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA20499(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-08-01 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1986-04-01 Publication of MA20499A1 publication Critical patent/MA20499A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/14—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom with carbocyclic rings directly attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MA20725A 1984-08-01 1985-08-01 Derives d'indole MA20499A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB848419575A GB8419575D0 (en)	1984-08-01	1984-08-01	Chemical compounds

Publications (1)

Publication Number	Publication Date
MA20499A1 true MA20499A1 (fr)	1986-04-01

Family

ID=10564759

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA20725A MA20499A1 (fr)	1984-08-01	1985-08-01	Derives d'indole

Country Status (42)

Country	Link
US (1)	US5037845A (fr)
JP (1)	JPH0623197B2 (fr)
KR (1)	KR930003759B1 (fr)
AT (1)	AT386196B (fr)
AU (1)	AU573878B2 (fr)
BE (1)	BE903006A (fr)
CA (1)	CA1241004A (fr)
CH (1)	CH666026A5 (fr)
CZ (1)	CZ280530B6 (fr)
DE (1)	DE3527648A1 (fr)
DK (1)	DK158942C (fr)
DO (1)	DOP1989004759A (fr)
EC (1)	ECSP941096A (fr)
EG (1)	EG17283A (fr)
ES (6)	ES8700234A1 (fr)
FI (1)	FI78466C (fr)
FR (1)	FR2568571B1 (fr)
GB (1)	GB8419575D0 (fr)
GR (1)	GR851850B (fr)
HK (1)	HK33289A (fr)
HU (1)	HU201738B (fr)
IE (1)	IE58122B1 (fr)
IL (1)	IL75986A (fr)
IS (1)	IS1430B6 (fr)
IT (1)	IT1207325B (fr)
JO (1)	JO1379B1 (fr)
KE (1)	KE3858A (fr)
LU (2)	LU86032A1 (fr)
MA (1)	MA20499A1 (fr)
MX (2)	MX159672A (fr)
NL (2)	NL188642C (fr)
NO (2)	NO164653C (fr)
NZ (1)	NZ212948A (fr)
PH (2)	PH22850A (fr)
PL (1)	PL146005B1 (fr)
PT (1)	PT80900B (fr)
SE (1)	SE452460B (fr)
SK (1)	SK277952B6 (fr)
SU (1)	SU1498386A3 (fr)
UA (1)	UA6329A1 (fr)
ZA (1)	ZA855818B (fr)
ZW (1)	ZW12485A1 (fr)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5270333A (en) *	1986-01-28	1993-12-14	Glaxo Group Limited	Indole derivatives
US5155218A (en)	1990-05-08	1992-10-13	Neurogenetic Corporation	Dna encoding human 5-ht1d receptors
US5935925A (en) *	1990-05-08	1999-08-10	Synaptic Pharmaceutical Corporation	Methods of treating migraine and compounds useful for such methods
GB9013845D0 (en) *	1990-06-21	1990-08-15	Glaxo Group Ltd	Process
GB9022250D0 (en) *	1990-10-12	1990-11-28	Glaxo Group Ltd	Medicaments
GB9101592D0 (en) *	1991-01-24	1991-03-06	Glaxo Group Ltd	Compositions
GB9102579D0 (en) *	1991-01-24	1991-03-27	Glaxo Group Ltd	Compositions
SK278998B6 (sk) *	1991-02-01	1998-05-06	Merck Sharp & Dohme Limited	Deriváty imidazolu, triazolu a tetrazolu, spôsob i
GB9104890D0 (en)	1991-03-08	1991-04-24	Glaxo Group Ltd	Compositions
AT399870B (de) *	1991-06-06	1995-08-25	Vita Invest Sa	Verfahren zur herstellung von 3-(2-(dimethylamino)ethyl)-n-methyl-1h-indol-5- ethansulfonamid
GB9209882D0 (en) *	1992-05-07	1992-06-24	Glaxo Lab Sa	Compositions
ES2059236B1 (es) *	1992-06-18	1995-06-16	Imidex S A	Procedimiento para la sintesis de la 3-(2-dimetilamino) etil)-n-metil-1h-indol-5-metanosulfonamida.
ES2055651B1 (es) *	1992-07-20	1995-03-01	Vita Invest Sa	Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
IL106445A (en) *	1992-07-30	1998-01-04	Merck Sharp & Dohme	History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
AT399871B (de) *	1993-02-15	1995-08-25	Vita Invest Sa	Verfahren zur herstellung von 2-carboxy-3-(2- (dimethylamino)ethyl)-n-methyl-1h-indol-5- methansulfonamid und dessen niederalkylestern
US5807571A (en) *	1993-05-06	1998-09-15	Lts Lohmann Therapie-Systeme Gmbh	Transdermal therapeutic systems for administering indole serotonin agonists
GB9401436D0 (en) *	1994-01-26	1994-03-23	Wellcome Found	Therapeutic heterocyclic compounds
ES2084560B1 (es) *	1994-03-09	1997-01-16	Almirall Lab	Procedimiento de preparacion de derivados el indol.
ES2079323B1 (es) *	1994-06-21	1996-10-16	Vita Invest Sa	Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
EP0804434A1 (fr) *	1994-08-02	1997-11-05	MERCK SHARP & DOHME LTD.	Derives de l'azetidine, de la pyrrolidine et de la piperidine
US5521197A (en)	1994-12-01	1996-05-28	Eli Lilly And Company	3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
US8022095B2 (en)	1996-08-16	2011-09-20	Pozen, Inc.	Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
AU4074897A (en) *	1996-09-18	1998-04-14	Eli Lilly And Company	A method for the prevention of migraine
WO1998015545A1 (fr) *	1996-10-08	1998-04-16	Eli Lilly And Company	Nouveaux agonistes de la serotonine 5-ht¿1f?
GB9714383D0 (en) *	1997-07-08	1997-09-10	Pfizer Ltd	Improved process
US6066092A (en) *	1997-11-06	2000-05-23	Cady; Roger K.	Preemptive prophylaxis of migraine device and method
US6416472B1 (en)	1997-11-06	2002-07-09	Edus Inc.	Method and device for measuring cognitive efficiency
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
AT500063A1 (de) *	1999-11-23	2005-10-15	Sandoz Ag	Beschichtete tablettenkerne
NZ528377A (en) *	2001-03-27	2005-05-27	Galen Chemicals Ltd	Intravaginal drug delivery devices for the administration of an antimicrobial agent
US20030013753A1 (en) *	2001-06-05	2003-01-16	Ronald Aung-Din	Transdermal migraine therapy
US8329734B2 (en)	2009-07-27	2012-12-11	Afgin Pharma Llc	Topical therapy for migraine
FR2827287B1 (fr) *	2001-07-13	2003-10-31	Servier Lab	Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2477088A1 (fr)	2002-02-22	2003-10-02	New River Pharmaceuticals Inc.	Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
US20060106227A1 (en) *	2002-06-13	2006-05-18	Dr Reddy's Laboratories Limited	3-'2-(Dimethylamino) ethyl!-n-methyl-1h-indole-5-methanesulfonamide and the succinate thereof
US20040068000A1 (en) *	2002-10-02	2004-04-08	Mintong Guo	Compression coated tablets
CN1176649C (zh) *	2002-10-16	2004-11-24	上海医药工业研究院	舒马普坦干粉吸入剂及其制备方法
EP1572647B1 (fr)	2002-12-20	2016-09-21	Basf Se	Préparation d´amines et de leurs intermédiaires
US20080213363A1 (en) *	2003-01-23	2008-09-04	Singh Nikhilesh N	Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
WO2004076403A1 (fr) *	2003-02-24	2004-09-10	Transform Pharmaceuticals, Inc.	Formes cristallines du sumatriptan, compositions pharmaceutiques et procedes
WO2004099141A1 (fr) *	2003-05-12	2004-11-18	Ramesh Babu Potluri	Nouveau procede pour la preparation de derives d'indole
BRPI0410807A (pt) *	2003-06-06	2006-06-27	Glaxo Group Ltd	composição farmacêutica, e, método pata tratar um mamìfero sofrendo de ou susceptìvel a condições associadas com dor cefálica
EP1644004A4 (fr) *	2003-06-20	2010-10-06	Ronald Aung-Din	Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
GB2407498B (en) *	2003-10-30	2008-06-11	Cipla Ltd	Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
US20060002989A1 (en) *	2004-06-10	2006-01-05	Ahmed Salah U	Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
DK1883451T3 (da)	2005-04-13	2011-03-14	Neuraxon Inc	Substituerede indolforbindelser med NOS-hæmmende virkning
WO2007070504A2 (fr) *	2005-12-13	2007-06-21	Morton Grove Pharmaceuticals, Inc.	Compositions orales liquides de sumatriptan stables et de gout agreable
US7989447B2 (en) *	2006-04-13	2011-08-02	Neuraxon, Inc.	1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
CN101687788A (zh)	2006-10-19	2010-03-31	奥斯拜客斯制药有限公司	取代的吲哚
US20090076121A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched sumatriptan
KR20100103799A (ko) *	2007-11-16	2010-09-28	네우렉슨 인코포레이티드	내장통을 치료하기 위한 인돌 화합물 및 방법
EP2220074A4 (fr) *	2007-11-16	2012-01-04	Neuraxon Inc	Composés d'indole 3,5-substitués ayant une activité d'inhibition de la réabsorption de la nos et de la noradrénaline
WO2009064505A1 (fr) *	2007-11-16	2009-05-22	The Arizona Board Of Regents On Behalf Of The University Of Arizona	Procédés de traitement de la douleur viscérale
WO2009128089A2 (fr) *	2008-02-11	2009-10-22	Matrix Laboratories Limited	Nouvelle forme de solvate de succinate de sumatriptan et procédé de préparation d'un sel de sumatriptan l'utilisant
US20090252791A1 (en) *	2008-04-02	2009-10-08	Venkata Nookaraju Sreedharala	Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug
KR101517415B1 (ko) *	2008-05-14	2015-05-07	에스케이바이오팜 주식회사	난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
EP2296652B1 (fr) *	2008-06-30	2017-11-08	Afgin Pharma, Llc	Traitement neuro-affectif régional topique
EP2337566A1 (fr) *	2008-10-22	2011-06-29	Novartis AG	Combinaisons pour le traitement de la migraine
EP2480197B1 (fr)	2009-09-25	2015-11-11	Dr. Reddy's Laboratories Ltd.	Formulations comprenant des composés triptan
US11337962B2 (en)	2009-09-25	2022-05-24	Upsher-Smith Laboratories, Llc	Formulations comprising triptan compounds
JP5660817B2 (ja) *	2010-07-21	2015-01-28	高田製薬株式会社	スマトリプタンコハク酸塩を含有する内用液剤
CN102432520B (zh) *	2011-11-21	2013-10-09	山东新华制药股份有限公司	3-[2-（二甲氨基）乙基]-n-甲基吲哚-5-甲烷磺酰胺琥珀酸盐的制备方法
US10716766B2 (en)	2015-03-02	2020-07-21	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoids
US10383816B2 (en)	2015-03-02	2019-08-20	Afgin Pharma, Llc	Topical regional neuro-affective therapy with cannabinoid combination products
US20180049994A1 (en)	2016-08-16	2018-02-22	Afgin Pharma, Llc	Topical regional neuro-affective therapy with caryophyllene

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE311728C (fr) *
US3322787A (en) *	1964-09-25	1967-05-30	Merck & Co Inc	Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
IT1036004B (it) *	1968-05-21	1979-10-30	Abc Ist Biolog Chem Spa	Acidt 3 indolil adetoidrossamici
US4283410A (en) *	1978-06-15	1981-08-11	Miles Laboratories, Inc.	3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
FR2488606A1 (fr) *	1980-08-12	1982-02-19	Glaxo Group Ltd	Derives indoliques, leur preparation et leurs applications en tant que medicaments
CH651551A5 (fr) *	1980-08-12	1985-09-30	Glaxo Group Ltd	Derives de l'indole, leur preparation et compositions pharmaceutiques les contenant.
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
GR79215B (fr) *	1982-06-07	1984-10-22	Glaxo Group Ltd
HU196752B (en) *	1983-12-06	1989-01-30	Glaxo Group Ltd	Process for production of medical compositions containing indole-derivatives and these compounds
GB8332434D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Production of chemical compounds

1984
- 1984-08-01 GB GB848419575A patent/GB8419575D0/en active Pending
1985
- 1985-07-26 GR GR851850A patent/GR851850B/el unknown
- 1985-07-30 CH CH3296/85A patent/CH666026A5/fr not_active IP Right Cessation
- 1985-07-30 JO JO19851379A patent/JO1379B1/en active
- 1985-07-31 HU HU852945A patent/HU201738B/hu unknown
- 1985-07-31 IS IS3034A patent/IS1430B6/is unknown
- 1985-08-01 ZW ZW124/85A patent/ZW12485A1/xx unknown
- 1985-08-01 LU LU86032A patent/LU86032A1/fr active Protection Beyond IP Right Term
- 1985-08-01 DE DE19853527648 patent/DE3527648A1/de active Granted
- 1985-08-01 PH PH32599A patent/PH22850A/en unknown
- 1985-08-01 FI FI852969A patent/FI78466C/fi not_active IP Right Cessation
- 1985-08-01 NL NLAANVRAGE8502171,A patent/NL188642C/xx not_active IP Right Cessation
- 1985-08-01 PL PL1985254800A patent/PL146005B1/pl unknown
- 1985-08-01 SE SE8503680A patent/SE452460B/sv not_active IP Right Cessation
- 1985-08-01 NZ NZ212948A patent/NZ212948A/xx unknown
- 1985-08-01 IT IT8548435A patent/IT1207325B/it active Protection Beyond IP Right Term
- 1985-08-01 JP JP60168664A patent/JPH0623197B2/ja not_active Expired - Lifetime
- 1985-08-01 KR KR1019850005553A patent/KR930003759B1/ko not_active IP Right Cessation
- 1985-08-01 CA CA000487992A patent/CA1241004A/fr not_active Expired
- 1985-08-01 BE BE0/215426A patent/BE903006A/fr not_active IP Right Cessation
- 1985-08-01 MA MA20725A patent/MA20499A1/fr unknown
- 1985-08-01 SU SU853935745A patent/SU1498386A3/ru active
- 1985-08-01 MX MX8273A patent/MX159672A/es unknown
- 1985-08-01 PT PT80900A patent/PT80900B/pt unknown
- 1985-08-01 FR FR8511790A patent/FR2568571B1/fr not_active Expired
- 1985-08-01 LU LU88266C patent/LU88266I2/xx unknown
- 1985-08-01 UA UA3935745A patent/UA6329A1/uk unknown
- 1985-08-01 EG EG460/85A patent/EG17283A/xx active
- 1985-08-01 AT AT0226685A patent/AT386196B/de not_active IP Right Cessation
- 1985-08-01 NO NO853046A patent/NO164653C/no not_active IP Right Cessation
- 1985-08-01 ES ES545810A patent/ES8700234A1/es not_active Expired
- 1985-08-01 ZA ZA855818A patent/ZA855818B/xx unknown
- 1985-08-01 IL IL75986A patent/IL75986A/xx not_active IP Right Cessation
- 1985-08-01 DK DK351185A patent/DK158942C/da not_active IP Right Cessation
- 1985-08-01 AU AU45689/85A patent/AU573878B2/en not_active Expired
- 1985-08-01 IE IE191885A patent/IE58122B1/en not_active IP Right Cessation
1986
- 1986-02-14 ES ES552047A patent/ES8801204A1/es not_active Expired
- 1986-10-22 PH PH34399A patent/PH24117A/en unknown
1987
- 1987-03-31 ES ES557482A patent/ES8801900A1/es not_active Expired
- 1987-03-31 ES ES557481A patent/ES8801789A1/es not_active Expired
- 1987-03-31 ES ES557483A patent/ES8801790A1/es not_active Expired
- 1987-03-31 ES ES557480A patent/ES8801788A1/es not_active Expired
1988
- 1988-12-16 MX MX1422188A patent/MX14221A/es unknown
1989
- 1989-02-07 KE KE3858A patent/KE3858A/xx unknown
- 1989-03-01 US US07/317,682 patent/US5037845A/en not_active Expired - Lifetime
- 1989-04-20 HK HK332/89A patent/HK33289A/xx not_active IP Right Cessation
- 1989-11-17 DO DO1989004759A patent/DOP1989004759A/es unknown
1991
- 1991-12-23 CZ CS914041A patent/CZ280530B6/cs not_active IP Right Cessation
- 1991-12-23 SK SK4041-91A patent/SK277952B6/sk unknown
1993
- 1993-06-11 NL NL930065C patent/NL930065I2/nl unknown
1994
- 1994-05-26 EC EC1994001096A patent/ECSP941096A/es unknown
- 1994-11-09 NO NO1994023C patent/NO1994023I1/no unknown

Also Published As

Publication number	Publication date
KR860001788A (ko)	1986-03-22
CZ280530B6 (cs)	1996-02-14
ES557480A0 (es)	1988-02-16
NL8502171A (nl)	1986-03-03
NZ212948A (en)	1989-05-29
CH666026A5 (fr)	1988-06-30
NL188642C (nl)	1992-08-17
MX159672A (es)	1989-08-02
DE3527648C2 (fr)	1993-08-26
IT8548435A0 (it)	1985-08-01
IS1430B6 (is)	1990-07-16
DK158942B (da)	1990-08-06
FI852969L (fi)	1986-02-02
HU201738B (en)	1990-12-28
PH24117A (en)	1990-03-05
ES552047A0 (es)	1987-12-16
FI78466B (fi)	1989-04-28
DK351185D0 (da)	1985-08-01
MX14221A (es)	1993-10-01
ECSP941096A (es)	1995-01-16
ES8801204A1 (es)	1987-12-16
EG17283A (en)	1992-06-30
US5037845A (en)	1991-08-06
DK351185A (da)	1986-02-02
IE851918L (en)	1986-02-01
HK33289A (en)	1989-04-28
ES8700234A1 (es)	1986-10-16
PL254800A1 (en)	1986-10-21
ES8801900A1 (es)	1988-03-01
IL75986A0 (en)	1985-12-31
BE903006A (fr)	1986-02-03
ES557482A0 (es)	1988-03-01
NL930065I1 (nl)	1993-09-01
PH22850A (en)	1989-01-19
AT386196B (de)	1988-07-11
PT80900A (en)	1985-09-01
SK404191A3 (en)	1995-09-13
SE452460B (sv)	1987-11-30
NO164653C (no)	1990-11-07
DE3527648A1 (de)	1986-02-13
PT80900B (pt)	1987-12-30
FR2568571A1 (fr)	1986-02-07
AU4568985A (en)	1986-02-06
NL930065I2 (nl)	1993-10-01
HUT40077A (en)	1986-11-28
JO1379B1 (en)	1986-11-30
KR930003759B1 (ko)	1993-05-10
ES545810A0 (es)	1986-10-16
FI852969A0 (fi)	1985-08-01
SK277952B6 (en)	1995-09-13
ATA226685A (de)	1987-12-15
CA1241004A (fr)	1988-08-23
ZW12485A1 (en)	1986-02-26
KE3858A (en)	1989-06-02
GR851850B (fr)	1985-11-26
LU88266I2 (fr)	1994-02-03
ES557483A0 (es)	1988-02-16
ES8801789A1 (es)	1988-02-16
SU1498386A3 (ru)	1989-07-30
DOP1989004759A (es)	1999-02-06
NO164653B (no)	1990-07-23
CZ404191A3 (en)	1993-04-14
SE8503680D0 (sv)	1985-08-01
ES8801790A1 (es)	1988-02-16
IL75986A (en)	1989-02-28
FR2568571B1 (fr)	1988-09-23
IT1207325B (it)	1989-05-17
SE8503680L (sv)	1986-02-02
ES557481A0 (es)	1988-02-16
IE58122B1 (en)	1993-07-14
LU86032A1 (fr)	1986-02-18
NO853046L (no)	1986-02-03
JPS6147464A (ja)	1986-03-07
NO1994023I1 (no)	1994-11-09
AU573878B2 (en)	1988-06-23
FI78466C (fi)	1989-08-10
JPH0623197B2 (ja)	1994-03-30
IS3034A7 (is)	1986-02-02
DK158942C (da)	1991-01-21
UA6329A1 (uk)	1994-12-29
ZA855818B (en)	1986-04-30
GB8419575D0 (en)	1984-09-05
PL146005B1 (en)	1988-12-31
ES8801788A1 (es)	1988-02-16

Publication	Publication Date	Title
MA20499A1 (fr)	1986-04-01	Derives d'indole
DK268285D0 (da)	1985-06-13	Dialkoxypyridinderivater
DK35785D0 (da)	1985-01-25	Tetrahydrocarbazolonderivater
DK243985A (da)	1985-12-02	Aminoalkylphenoxyderivater
DE3463503D1 (de)	1987-06-11	Sulfonamido-benzamide derivatives
MC1696A1 (fr)	1986-07-18	Derives d'ethylenediaminemonoamide
DK615186A (da)	1987-06-21	Substituerede 5,6-dialkoxyquinazolinderivater
DE3566887D1 (de)	1989-01-26	Flavanon derivatives
DK501085D0 (da)	1985-10-31	Substituerede benzimidazolderivater
PT74710A (fr)	1982-05-01	Nouveaux derives d'aminoethoxy-4 isopropyl-5 methyl-2-phenol
DK460785D0 (da)	1985-10-08	Substituerede furanylderivater
DK320585A (da)	1986-01-14	Fluorallylaminderivater
DK360888A (da)	1989-01-02	3',4'-dinitrogen-substituerede epipodophyllotoxinglucosidderivater
DK702688D0 (da)	1988-12-16	Epipodophyllotoxin-glucosid 4'-acylderivater
MC1616A1 (fr)	1985-07-18	Derives d'imidazobenzodiazepine
MC1650A1 (fr)	1986-04-07	Derives de l'imidazole
MC1438A1 (fr)	1982-12-06	Derives d'oxadiazolopyrimidine
DE3565100D1 (de)	1988-10-27	Cycloalkane-indene-carboximidamide derivatives
DK267190D0 (da)	1990-11-07	13-substitueret-5-ketomilbemycinderivater
MC1556A1 (fr)	1984-08-31	Derives de l'acridanone
FR2602233B1 (fr)	1990-08-17	Derives de l'isoquinoleine
MC1576A1 (fr)	1985-02-04	Derives d'imidazole
ES532340A0 (es)	1985-07-01	Derivados de 4, 4 -alquilendipiperidina
FR2603282B1 (fr)	1990-12-14	Derives d'isoquinoleine
MC1816A1 (fr)	1988-03-18	Derives d'isoquinoleine